Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar

NCT ID: NCT00810264

Last Updated: 2019-11-29

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

2499 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-12-31

Study Completion Date

2018-11-02

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this study is to confirm the long-term safety and reliability of the Corox OTW BP left ventricular (LV) pacing lead. As a condition of approval, the FDA required that a registry documenting the post approval clinical experience of these leads be designed and implemented.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study is an FDA-required, multi-center, prospective, non-randomized, data collection registry. Eligible patients must have been successfully implanted with a Corox OTW BP, Corox OTW-S BP, or Corox OTW-L BP LV lead with a BIOTRONIK CRT device and consented and enrolled between 7-180 days following implant. At least 2500 patients will be enrolled in this post-approval registry, and each patient will be followed for five years post-implant.

Safety will be evaluated based on the analysis of the overall incidence of lead-related adverse events that require additional invasive intervention. In addition, each individual adverse event will be separately investigated. Lead parameters for sensing, pacing thresholds, and impedance will also be evaluated. Reporting of all adverse events will be performed twice a year in order to identify and characterize any trends in adverse events, failure modes, or failure rates.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Congestive Heart Failure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Data Collection Group

CRT Therapy - LV Lead Registry

Intervention Type DEVICE

Collecting long-term safety and efficacy data on a market-released left ventricular lead.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

CRT Therapy - LV Lead Registry

Collecting long-term safety and efficacy data on a market-released left ventricular lead.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Successfully implanted BIOTRONIK CRT system, including a Corox BP LV lead, from 7-180 days prior to enrollment
* Able to understand the nature of the registry and give informed consent
* Available for follow-up visits on a regular basis at the investigational site
* Age greater than or equal to 18 years

Exclusion Criteria

* Enrolled in any IDE clinical study
* Planned cardiac surgical procedures or interventional measures within the next 6 months
* Expected to receive a heart transplant within 1 year
* Life expectancy less than 1 year
* Presence of another life-threatening, underlying illness separate from their cardiac disorder
* Pregnancy
* Inability to provide date of implant, devices implanted, age, gender, and whether the patient experienced any protocol-defined adverse events since implant
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Biotronik, Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Birmingham, Alabama, United States

Site Status

Glendale, Arizona, United States

Site Status

Mesa, Arizona, United States

Site Status

Phoenix, Arizona, United States

Site Status

Scottsdale, Arizona, United States

Site Status

Tucson, Arizona, United States

Site Status

Anaheim, California, United States

Site Status

Fairfield, California, United States

Site Status

Fountain Valley, California, United States

Site Status

Glendale, California, United States

Site Status

Hawthorne, California, United States

Site Status

Inglewood, California, United States

Site Status

Los Angeles, California, United States

Site Status

National City, California, United States

Site Status

Northridge, California, United States

Site Status

Orange, California, United States

Site Status

Rancho Mirage, California, United States

Site Status

Santa Barbara, California, United States

Site Status

Torrance, California, United States

Site Status

Ventura, California, United States

Site Status

Watsonville, California, United States

Site Status

Aurora, Colorado, United States

Site Status

Boulder, Colorado, United States

Site Status

Danbury, Connecticut, United States

Site Status

Brooksville, Florida, United States

Site Status

Davenport, Florida, United States

Site Status

Melbourne, Florida, United States

Site Status

Naples, Florida, United States

Site Status

New Smyrna Beach, Florida, United States

Site Status

St. Petersburg, Florida, United States

Site Status

Tampa, Florida, United States

Site Status

Macon, Georgia, United States

Site Status

Urbana, Illinois, United States

Site Status

Fort Wayne, Indiana, United States

Site Status

Valparaiso, Indiana, United States

Site Status

Owensboro, Kentucky, United States

Site Status

Covington, Louisiana, United States

Site Status

Hammond, Louisiana, United States

Site Status

Lafayette, Louisiana, United States

Site Status

Bangor, Maine, United States

Site Status

Baltimore, Maryland, United States

Site Status

Cumberland, Maryland, United States

Site Status

Lanham, Maryland, United States

Site Status

Rockville, Maryland, United States

Site Status

Burlington, Massachusetts, United States

Site Status

Worcester, Massachusetts, United States

Site Status

Ann Arbor, Michigan, United States

Site Status

Lansing, Michigan, United States

Site Status

Lapeer, Michigan, United States

Site Status

Saginaw, Michigan, United States

Site Status

Wyoming, Michigan, United States

Site Status

Ypsilanti, Michigan, United States

Site Status

Tupelo, Mississippi, United States

Site Status

Crystal City, Missouri, United States

Site Status

St Louis, Missouri, United States

Site Status

Las Vegas, Nevada, United States

Site Status

Glen Ridge, New Jersey, United States

Site Status

New York, New York, United States

Site Status

Rochester, New York, United States

Site Status

Gastonia, North Carolina, United States

Site Status

Winston-Salem, North Carolina, United States

Site Status

Columbus, Ohio, United States

Site Status

Middletown, Ohio, United States

Site Status

Steubenville, Ohio, United States

Site Status

Toledo, Ohio, United States

Site Status

Oklahoma City, Oklahoma, United States

Site Status

Salem, Oregon, United States

Site Status

Chinchilla, Pennsylvania, United States

Site Status

Lancaster, Pennsylvania, United States

Site Status

Philadelphia, Pennsylvania, United States

Site Status

Pottstown, Pennsylvania, United States

Site Status

Yardley, Pennsylvania, United States

Site Status

Columbia, South Carolina, United States

Site Status

Greenville, South Carolina, United States

Site Status

Spartanburg, South Carolina, United States

Site Status

Chattanooga, Tennessee, United States

Site Status

Amarillo, Texas, United States

Site Status

Brownsville, Texas, United States

Site Status

Corpus Christi, Texas, United States

Site Status

Dallas, Texas, United States

Site Status

Kingwood, Texas, United States

Site Status

McKinney, Texas, United States

Site Status

Nacogdoches, Texas, United States

Site Status

Fredericksburg, Virginia, United States

Site Status

Spokane, Washington, United States

Site Status

Yakima, Washington, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Good ED, Cakulev I, Orlov MV, Hirsh D, Simeles J, Mohr K, Moll P, Bloom H. Long-Term Evaluation of Biotronik Linox and Linox(smart) Implantable Cardioverter Defibrillator Leads. J Cardiovasc Electrophysiol. 2016 Jun;27(6):735-42. doi: 10.1111/jce.12971. Epub 2016 May 3.

Reference Type DERIVED
PMID: 26990515 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Document Type: Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CELESTIAL

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Personalized CRT - PSR
NCT03723265 COMPLETED